The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

Registros relacionados

• Subcutaneous immunoglobulin replacement therapy: the European experience.
  por: Chapel, H, et al.
  Publicado em: (2013)
• Intravenous immunoglobulin therapy.
  por: Chapel, H
  Publicado em: (1996)
• Home intravenous immunoglobulin therapy.
  por: Chapel, H, et al.
  Publicado em: (1988)
• Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients
  por: Martin Adriana, et al.
  Publicado em: (2012-11-01)
• Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy.
  por: Bhole, M, et al.
  Publicado em: (2008)